Dr. Lei Wang is a faculty member in the Department of Biomedical Engineering at Oregon Health & Science University (OHSU) with a joint appointment in the OHSU Knight Cancer Institute. With expertise in fluorescence chemistry and optical imaging, Dr. Wang leads an innovative research program aimed at developing novel fluorescent probes and imaging technologies to address clinical challenges. His research interests include near-infrared (NIR) contrast agents for real-time surgical navigation, smart molecular probes for cancer-targeted imaging, and NIR fluorophores for the early detection of cancer and neurodegenerative diseases. Dr. Wang's research is supported by funding from the National Institutes of Health, Knight Cancer Institute, Brenden Colson Center for Pancreatic Care, and Collins Medical Trust. Motivated by transformative potential of chemistry-driven solutions in precision medicine, Dr. Wang and his team are devoted to bridging the gap between clinical needs and basic sciences through innovative imaging technologies.